<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599813488554</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599813488554</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Salivary Duct Carcinoma of the Accessory Parotid Gland</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Funamura</surname><given-names>Jamie L.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813488554">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Aouad</surname><given-names>Rony K.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599813488554">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ramsamooj</surname><given-names>Rajendra</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0194599813488554">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Donald</surname><given-names>Paul J.</given-names></name>
<degrees>MD, FRCS</degrees>
<xref ref-type="aff" rid="aff1-0194599813488554">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599813488554"><label>1</label>Department of Otolaryngology, University of California Davis, Sacramento, California, USA</aff>
<aff id="aff2-0194599813488554"><label>2</label>Department of Otolaryngology, Head and Neck Surgery, University of Kentucky, Lexington, Kentucky, USA</aff>
<aff id="aff3-0194599813488554"><label>3</label>Department of Pathology &amp; Laboratory Medicine, University of California Davis, Sacramento, California, USA</aff>
<author-notes>
<corresp id="corresp1-0194599813488554">Jamie L. Funamura, MD, Department of Otolaryngology, University of California Davis, 2521 Stockton Blvd, Suite 7200, Sacramento, CA 95817, USA. Email: <email>jamie.funamura@ucdmc.ucdavis.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>149</volume>
<issue>2</issue>
<fpage>347</fpage>
<lpage>348</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>2</month>
<year>2013</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>4</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>4</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<kwd-group>
<kwd>salivary duct carcinoma</kwd>
<kwd>accessory parotid gland</kwd>
<kwd>salivary tumors</kwd>
<kwd>head and neck</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>A small percentage of parotid tumors (from 1.0%-7.7%) occurs in accessory parotid gland tissue, defined as salivary gland tissue adjacent to Stensen’s duct and separate from the main body of the parotid gland.<sup><xref ref-type="bibr" rid="bibr1-0194599813488554">1</xref>,<xref ref-type="bibr" rid="bibr2-0194599813488554">2</xref></sup> Salivary duct carcinoma is a rare neoplasm, comprising 1% of salivary gland malignancies.<sup><xref ref-type="bibr" rid="bibr3-0194599813488554">3</xref></sup> We present herein the first case reported in the English literature of a salivary duct carcinoma of the accessory parotid gland.</p>
<sec id="section1-0194599813488554" sec-type="cases">
<title>Case Presentation</title>
<p>A 76-year-old woman was referred to our clinic for a 3-month history of a firm, enlarging mass of her left cheek. Physical examination revealed a 3-cm mass, mobile in her mid-cheek. Fine-needle aspiration biopsy was consistent with a poorly differentiated carcinoma that could not be further delineated. A computed tomography (CT) scan demonstrated a large heterogeneously enhancing, poorly marginated, lobulated mass anterior to the main parotid gland and abutting the masseter muscle. No pathological-appearing nodes were visualized (see <xref ref-type="fig" rid="fig1-0194599813488554"><bold>Figure 1</bold></xref>).</p>
<fig id="fig1-0194599813488554" position="float">
<label>Figure 1.</label>
<caption>
<p>Computed tomography scan demonstrating a 2 × 4-cm mass abutting the anterior tail of the left parotid gland.</p>
</caption>
<graphic xlink:href="10.1177_0194599813488554-fig1.tif"/>
</fig>
<p>The patient underwent a left parotidectomy via a modified Blair incision. The tumor was a 5 × 4 × 4-cm smooth mass abutting the masseter and extending toward the anterior wall of the maxillary sinus. It was distinct from the main body of the parotid gland. Histology demonstrated tumor cells arranged in cribriform, papillary, and solid patterns (see <xref ref-type="fig" rid="fig2-0194599813488554"><bold>Figure 2</bold></xref>) characteristic of salivary duct carcinoma. The patient declined adjuvant radiation therapy, and she died 2 years later after being admitted to the hospital for sepsis.</p>
<fig id="fig2-0194599813488554" position="float">
<label>Figure 2.</label>
<caption>
<p>Low power view of hematoxylin and eosin staining of tumor cells arranged in cribriform (bottom left), papillary (top right), and solid (middle) patterns. The intraductal cribriform pattern is particularly characteristic of salivary duct carcinoma.</p>
</caption>
<graphic xlink:href="10.1177_0194599813488554-fig2.tif"/>
</fig>
<p>Exemption from review was obtained from the Institutional Review Board of the University of California, Davis.</p>
</sec>
<sec id="section2-0194599813488554" sec-type="discussion">
<title>Discussion</title>
<p>Salivary duct carcinoma is a rare and aggressive malignancy comprising 1% of salivary carcinomas and is most commonly found in the parotid gland. It typically presents as a rapidly enlarging mass with facial nerve weakness and regional lymph node metastasis. Local and regional recurrences occur in 30% and 60%, respectively. Fifty percent of patients will develop distant metastases, and 5-year survival is estimated at 50%.<sup><xref ref-type="bibr" rid="bibr3-0194599813488554">3</xref></sup></p>
<p>Tumors of the accessory parotid gland have been reported as 1% to 7.7% of parotid tumors.<sup><xref ref-type="bibr" rid="bibr1-0194599813488554">1</xref>,<xref ref-type="bibr" rid="bibr2-0194599813488554">2</xref></sup> A high degree of suspicion is needed to not overlook a tumor of the accessory gland during the workup of a mid-cheek mass. A thorough physical examination along with fine-needle aspiration biopsy and CT scanning are the mainstays of workup.<sup><xref ref-type="bibr" rid="bibr4-0194599813488554">4</xref></sup></p>
<p>The standard parotidectomy remains the general accepted surgical approach due to lower rates of facial nerve injury and tumor recurrence.<sup><xref ref-type="bibr" rid="bibr1-0194599813488554">1</xref>,<xref ref-type="bibr" rid="bibr2-0194599813488554">2</xref>,<xref ref-type="bibr" rid="bibr4-0194599813488554">4</xref>,<xref ref-type="bibr" rid="bibr5-0194599813488554">5</xref></sup> Superior or inferior extension of this incision is further advocated if necessary for better visualization.<sup><xref ref-type="bibr" rid="bibr4-0194599813488554">4</xref></sup> Transfacial or transoral approaches through the buccal mucosa are generally not advised due to difficulties of exposure and facial nerve identification.<sup><xref ref-type="bibr" rid="bibr1-0194599813488554">1</xref>,<xref ref-type="bibr" rid="bibr5-0194599813488554">5</xref></sup> It is thought that small (T1 and T2) low-grade malignancies may be sufficiently managed by wide excision without concomitant parotidectomy because the accessory parotid gland is an independent island of salivary tissue. High-grade malignancies, large tumor size, or locoregional spread are indications for total parotidectomy and neck dissection. Complications from surgery are similar to that of a standard parotidectomy, with the possibility of hematoma, seroma, facial nerve injury, salivary fistula, and tumor recurrence. Similar to its role in the management of other salivary gland malignancies, adjuvant postoperative radiation therapy is typically reserved for high-grade malignancies and advanced-stage disease.<sup><xref ref-type="bibr" rid="bibr4-0194599813488554">4</xref></sup></p>
</sec>
<sec id="section3-0194599813488554" sec-type="conclusions">
<title>Conclusion</title>
<p>We present a previously unreported case of salivary duct carcinoma of the accessory parotid gland. An accessory parotid tumor should be considered in the differential of a mid-cheek mass with workup for a salivary gland malignancy. Lower rates of facial nerve injury and tumor recurrence are noted with a standard parotidectomy incision compared with direct cheek or perioral approaches.</p>
</sec>
<sec id="section4-0194599813488554">
<title>Author Contributions</title>
<p><bold>Jamie L. Funamura</bold>, data acquisition, authorship, literature review; <bold>Rony K. Aouad</bold>, data acquisition, surgery, manuscript edits, final approval; <bold>Rajendra Ramsamooj</bold>, data acquisition, analysis, clinical consultation, manuscript edits, final approval; <bold>Paul J. Donald</bold>, data acquisition, surgery, final approval.</p>
</sec>
<sec id="section5-0194599813488554">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
<p>This article was presented at the 2012 AAO-HNSF Annual Meeting &amp; OTO EXPO; September 9-12, 2012; Washington, DC.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599813488554">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>FE</given-names></name>
<name><surname>Spiro</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Tumors arising in accessory parotid tissue</article-title>. <source>Am J Surg</source>. <year>1979</year>;<volume>138</volume>:<fpage>576</fpage>-<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr2-0194599813488554">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Perzik</surname><given-names>SL</given-names></name>
<name><surname>White</surname><given-names>IL</given-names></name>
</person-group>. <article-title>Surgical management of preauricular tumors of the accessory parotid apparatus</article-title>. <source>Am J Surg</source>. <year>1966</year>;<volume>112</volume>:<fpage>498</fpage>-<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr3-0194599813488554">
<label>3.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Weidner</surname><given-names>N</given-names></name>
<name><surname>Cote</surname><given-names>RJ</given-names></name>
<name><surname>Suster</surname><given-names>S</given-names></name>
<name><surname>Weiss</surname><given-names>LM</given-names></name>
</person-group>, eds. <source>Modern Surgical Pathology</source>. <edition>2nd ed.</edition> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>; <year>2009</year>:<fpage>274</fpage>-<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr4-0194599813488554">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klotz</surname><given-names>DA</given-names></name>
<name><surname>Coniglio</surname><given-names>JU</given-names></name>
</person-group>. <article-title>Prudent management of the mid-cheek mass: revisiting the accessory parotid gland tumor</article-title>. <source>Laryngoscope</source>. <year>2000</year>;<volume>110</volume>:<fpage>1627</fpage>-<lpage>1632</lpage>.</citation>
</ref>
<ref id="bibr5-0194599813488554">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodino</surname><given-names>W</given-names></name>
<name><surname>Shaha</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Surgical management of accessory parotid tumors</article-title>. <source>J Surg Oncol</source>. <year>1993</year>;<volume>54</volume>:<fpage>153</fpage>-<lpage>156</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>